These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 390784)

  • 1. Use of antithymocyte globulin for reversal of acute allograft rejection.
    Shield CF; Cosimi AB; Tolkoff-Rubin N; Rubin RH; Herrin J; Russell PS
    Transplantation; 1979 Dec; 28(6):461-4. PubMed ID: 390784
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F; Mendez-Picon G; Thomas J; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of antilymphoblast globulin in the treatment of renal allograft rejection.
    Howard RJ; Condie RM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):473-4. PubMed ID: 7022876
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 7. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 9. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD
    Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
    [No Abstract]   [Full Text] [Related]  

  • 10. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 11. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 12. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
    Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.